In response to an overwhelming demand for its Tamiflu flu treatment,
Roche announced it would build another production plant in North
America later this year. The Swiss manufacturer earlier said it had
orders from 25 countries; some would have to wait for up to two
years for doses to guard against what the WHO has warned is a real
danger of a global pandemic caused by the avian flu.